The SARS-CoV-2 Omicron BA.1 spike G446S potentiates HLA-A*24:02-restricted T cell immunity
Motozono, C.; Toyoda, M.; Tan, T. S.; Hamana, H.; Aritsu, Y.; Miyashita, Y.; Oshiumi, H.; Nakamura, K.; Okada, S.; Udaka, K.; Kitamatsu, M.; Kishi, H.; Ueno, T.
Show abstract
Although the Omicron variant of the SARS-CoV-2 virus is resistant to neutralizing antibodies, it retains susceptibility to cellular immunity. Here, we characterized vaccine-induced T cells specific for various SARS-CoV-2 variants and identified HLA-A*24:02-restricted CD8+ T cells that strongly suppressed Omicron BA.1 replication. Mutagenesis analyses revealed that a G446S mutation, located just outside the N-terminus of the cognate epitope, augmented TCR recognition of this variant. In contrast, no enhanced suppression of replication was observed against cells infected with the prototype, Omicron BA.2, and Delta variants that express G446. The enhancing effect of the G446S mutation was lost when target cells were treated with inhibitors of tripeptidyl peptidase II, a protein that mediates antigen processing. These results demonstrate that the G446S mutation in the Omicron BA.1 variant affects antigen processing/presentation and potentiates antiviral activity by vaccine-induced T cells, leading to enhanced T cell immunity towards emerging variants.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- B cells engineered to express an anti-HIV antibody allow memory retention, class switch recombination and clonal selection in mice 97%
- Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains 96%
- A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines 96%
Similar papers in this journal
- A subset of Memory B-derived antibody repertoire from 3-dose vaccinees is ultrapotent against diverse and highly transmissible SARS-CoV-2 variants, including Omicron 97%
- Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant 97%
- SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies 97%
Similar papers in this journal
Similar papers in this journal
- Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals 97%
- Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants 96%
- HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells 96%
Similar papers in this journal
- Quality of vaccination-induced T cell responses is conveyed by polyclonality and high, but not maximum, antigen receptor avidity 96%
- Mucosal immunity against SARS-CoV-2 variants of concern including Omicron following vaccination 96%
- Distinct CD8+ T Cell Programming in the Tumor Microenvironment Contributes to Sex Bias in Bladder Cancer Outcome 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.